Gene polymorphisms in the apolipoprotein E (APOE) gene of patients with MS have been reported by most as not associated with an increased risk of developing MS, but different groups found a discordant effect of this locus on the severity and/or disease progression in individuals already affected with MS [1, 4]. Here, APOE is linked to myeloid sarcoma.